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After ultraviolet exposure Langerhans cells (epidermal
CD1aF cells) disappear from the healthy skin, and
CD11bF macrophage-like cells, which are reported to
produce interleukin-10, appear in a matter of days.
These phenomena are related to the ultraviolet-
induced local suppression of contact hypersensitivity
reactions. A defect in this suppression might allow
inadvertent immune reactions to develop after ultravi-
olet (over)exposure; i.e., it could cause ultraviolet-B-
induced polymorphous light eruption. In order to test
this we first exposed buttock skin of eight healthy
volunteers to six minimal erythema doses from Philips
TL12 lamps, and indeed observed a dramatic disap-
pearance of CD1aF cells 48 and 72 h later, at which
time the number of CD11bF cells increased in the
dermis, and some occurred in the epidermis. The
epidermis thickened and showed large defects, filled
by CD11bF cells, just below the stratum corneum. In
Solar ultraviolet (UV) radiation, especially UVB (280–315 nm), is a very potent activator of photochemicalreactions: we are all familiar with resulting effects like‘‘photochemical smog’’ and ‘‘photodegradation’’ ofplastics and other compounds. Organic molecules such
as proteins and DNA can react to UVB and be damaged (Jung
et al, 1995; de Gruijl, 1997). It is, therefore, likely that UV radiation
induces a broad range of effects and physiologic reactions in the
skin. Obviously, the skin needs to be very well adapted to this
natural photochemical stress. The skin has, for example, efficient
mechanisms to repair or replace photodamaged cells. Another
plausible adaptive mechanism of the skin to UVB radiation lies in
the modulation of the immune system: exposure to UVB causes
suppression of cellular immunity (Yoshikawa et al, 1990; Cooper,
1996). In previous research this came to light as an adverse effect
on health. Tumor rejection and the immunization against microbial
pathogens are markedly reduced in animal models after exposure
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10 patients with polymorphous light eruption (five
with a normal minimal erythema dose and five with
a low minimal erythema dose) CD1aF cells were
present in the epidermis as well as in the dermis before
exposure. Strikingly, these cells were still present in
considerable number at 48 and 72 h after exposure to
six minimal erythema doses. CD11bF cells already
present in the dermis before ultraviolet exposure,
increased after ultraviolet exposure, and subsequently
also invaded the epidermis. Despite the six minimal
erythema doses, there were no apparent defects in the
epidermis of the polymorphous light eruption patients.
This deviant early response to ultraviolet radiation is
likely to be of direct relevance to the polymorphous
light eruption and is perhaps useful as a diagnostic
criterion. Key words: Langerhans cell, macrophages, photo-
dermatoses, ultraviolet immunosuppression. J Invest Dermatol
113:4–10, 1999
to UV radiation (Gensler et al, 1995; Jeevan et al, 1995; Halliday
and Norval, 1997). On reconsideration, however, this UV-induced
immunosuppression can be thought of as a primarily sound physio-
logic reaction. First, it should be noted that all healthy humans
consistently display this UV-induced immunosuppression at
sufficiently high dosages (Cooper et al, 1992). Because of its
photochemical activity, UV radiation can modify proteins and
other molecules, and thus create neo-antigens that could provoke
(auto-)immune reactivity (Natali and Tan, 1973; Norris et al, 1988).
From this perspective UV-induced immunosuppression is a very
desirable mechanism to prevent a persistent, disruptive immune
reactivity against sun-exposed skin. What if this immunosuppression
is not adequate? What kind of pathology would evolve? A UV-
induced ‘‘sun allergy’’ would be most plausible. UVB-triggered
polymorphous light eruption (PLE) would, therefore, seem a likely
candidate for exploring this possible pathogenic mechanism.
Patients with PLE are sensitive to UVB, UVA, and sometimes
even to visible light. These patients develop papules and eczema,
mostly on areas that are exposed to sunlight (Grabczyska and Hawk,
1997; Epstein, 1997; Salomon et al, 1997). It is often suggested
that PLE is a delayed-type hypersensitivity reaction (type IV)
because there is usually a clear delay (hours to days) between the
exposure to UV and the appearance of skin lesions (Epstein, 1997;
Norris et al, 1988; Verheyen et al, 1995). The histology of
lesionalPLE skin shows dense lymphocytic infiltrates. These infilt-
rates are initially dominated by CD41 lymphocytes, but at 72 h
after the UV provocation CD81 T cells outnumber CD41 T cells
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(Norris et al, 1988; Holze et al, 1995). These phenomena indicate
that a cellular-mediated immune reactivity is involved in PLE.
UVB can inhibit the antigen-presenting capacity of, e.g.,
Langerhans cells (Goettsch et al, 1993; Krutmann et al, 1994;
Ullrich, 1995; Bacci et al, 1996; Beissert and Granstein, 1996).
After UV radiation, Langerhans cells with UV-damaged DNA
migrate from the epidermis and become detectable in the draining
lymph nodes (Sontag et al, 1995), but UVB exposure can also kill
epidermal Langerhans cells in the epidermis (Mommaas et al, 1993).
Furthermore, immunomodulatory compounds such as interleukin-
10, prostaglandin E2, and tumor necrosis factor-α are released in
the UV-exposed skin (Cooper, 1996; Boonstra and Savelkoul,
1997; Halliday and Norval, 1997). CD11b1 macrophage-like cells
infiltrate the dermis and epidermis after UVB exposure and were
found to be potent interleukin-10 producers (Kang et al, 1994,
1998). UVB-modified antigen presentation can render Th1 cells,
which are involved in delayed-type hypersensitivity reactions,
anergic (for reviews see Ullrich, 1995; 1996; Boonstra and
Savelkoul, 1997; Halliday and Norval, 1997).
Hence, in the epidermis of healthy individuals Langerhans cells
disappear after UVB (over)exposure and within a few days CD11b1
macrophage-like cells appear, which can suppress cellular immunity.
As was also suggested by Dr. Cooper (personal communication),
we hypothesized that a defect in this influx of CD11b1 macrophage-
like cells would lead to illicit immune reactivity. This immune
reactivity could be involved in the pathogenesis of a UVB-
induced PLE.
To investigate this possible pathogenic mechanism, a group of
PLE patients was studied. All patients reacted pathologically to
UVB irradiation, developing vesicles, papules, or eczema. For
comparison a control group consisting of healthy volunteers was
studied. A small area of unaffected buttock skin of all participants
was overexposed to UVB and skin biopsies were taken at successive
time points following the exposure. In order to assess whether
immunocellular responses were altered in the unaffected skin of
PLE patients, immunohistochemical stainings were done to study
shifts in CD1a1 (Langerhans cells) and CD11b1 (macrophage-like
cells) cell populations. These cells were further phenotyped by
double staining.
MATERIALS AND METHODS
Subjects Five patients with PLE and normal sunburn sensitivity (two
males and three females, ages between 28 and 49 y), five patients with
PLE and extreme sunburn sensitivity (five males, ages between 45 and
82 y) and eight healthy individuals (four males and four females, aged
between 21 and 43 y) were studied. The diagnosis PLE was based on the
patient’s history and on provocation with daily exposures of UVB, UVA-
1, and visible light on restricted areas of the upper arms, a standard
procedure in our dermatologic clinic. In all patients who were included,
papular or eczematous lesions occurred in the UVB-exposed skin either
with or without a similar reaction in the UVA-exposed skin. In some
patients, who were extremely sensitive to sunburn a pathologic reaction
to visible light was also observed. With the exception of two extremely
sunburn-sensitive patients, most included patients had a season-dependent
exacerbation of the disease. Patients who had received phototherapy or
who were under medication (e.g., corticosteroids) and patients and volun-
teers whose buttock skin was exposed to sunlight less than 2 mo ago, were
excluded. Informed consent was obtained from patients and volunteers.
This study was approved by the medical ethical committee of the University
Hospital in Utrecht.
Phototesting procedures The minimal erythema dose (MED) of the
buttock skin of the participants in this study was determined using a Philips
TL12 lamp [57.5% of UV output in UVB (280–315 nm)] and a testing
device with nine windows (2 3 9 mm each), which open and close
sequentially to expose the underlying skin for different periods of time (in
a geometrical series, e.g., from 12.5 to 200 s). The small areas of irradiated
skin were examined at 6 and 24 h and the area showing minimal perceptible
redness, not necessarily with discernible borders, was taken to correspond
to the MED. MED ranged from 350 to 750 J per m2 UV in healthy
individuals, from 245 to 490 J per m2 UV in PLE patients with a normal
MED, and from 8.8 to 70 J per m2 UV in PLE patients with a low MED.
Subsequently, the (unaffected) buttock skin was exposed to 6 MED UV
(again with Philips TL12). Three millimeter punch biopsies were obtained
24 h and 48 h or 48 h and 72 h after UV exposure, together with one
additional control biopsy from the unirradiated skin. Specimens were snap
frozen in liquid nitrogen, embedded in OCT-compound (Tissue-Tek,
Sakura, Zoeterwoude, the Netherlands) and stored at –40°C until further
processing.
Antibodies As primary antibodies, monoclonal antibodies CD1a (DAKO
A/S, Glostrup, Denmark, diluted 1:60), CD11b (Immunotech, Marseilles,
France, diluted 1:50), and CD68 (DAKO A/S, diluted 1:50) were used. The
fluorescein isothiocyanate (FITC)-conjugated primary antibodies CD1a and
CD11b were purchased from Ortho Diagnostic Systems (Beerse, Belgium,
diluted 1:20) and Immunotech (diluted 1:60), respectively. The murine
monoclonal antibody Lag was a kind gift from Professor Imamura
(Department of Dermatology, Kyoto University, Kyoto, Japan). Biotinyl-
ated horse anti-mouse immunoglobulin (Vector, Burlingame, CA, diluted
1:800) was used as a secondary antibody. Alkaline phosphatase-labeled
F(ab) fragments of sheep anti-FITC (Boehringer Mannheim GmbH,
Mannheim, Germany, diluted 1:400) or horseradish peroxidase-conjugated
avidin–biotin complex (DAKO A/S, diluted 1:50) were used as
detecting reagents.
Immunohistochemistry Frozen skin sections (6 µm) on 3-amino-
propyltriethoxysilane-coated glass slides were fixed for 10 min in 100 ml
dry acetone containing 50 µl 30% H2O2 at room temperature and incubated
for 20 min with a blocking reagent [phosphate-buffered saline (PBS)
containing 10% normal human serum, 10% normal horse serum and 10%
normal mouse serum] to prevent nonspecific binding. The skin sections
were incubated with the primary antibody (diluted in blocking reagent)
for 1 h. The glass slides were then washed three times with PBS, containing
0.05% Tween 20.
Subsequently, skin sections were incubated for 1 h with a biotinylated
horse anti-mouse antibody (diluted in blocking reagent) following incuba-
tion with an horseradish peroxidase-conjugated avidin–biotin complex
(diluted in PBS/0.05% Tween) for 30 min. Antibody binding was visualized
by incubating the sections in 0.1 M acetate buffer (pH 5 5) containing
20 mg 3-amino-ethyl-carbazole (Sigma, St. Louis, MO) and 100 µl 30%
H2O2 per 100 ml. The skin sections were counter-stained with Mayer’s
hematoxylin. Double staining reactions were done to characterize further
the CD1a1 and CD11b1 cells.
For the double staining (Lag/CD1a-FITC and CD68/CD11b-FITC)
the skin sections were fixed and preincubated as described above. The skin
sections were then incubated with the unconjugated antibody (Lag or
CD68; diluted in blocking reagent) for 1 h and with a biotinylated horse
anti-mouse antibody (diluted in blocking reagent) also for 1 h. The sections
were incubated for 20 min with a blocking reagent containing PBS and
10% normal mouse serum and subsequently incubated for 1 h with the
FITC-conjugated antibody CD1a or CD11b (diluted in 10% normal mouse
serum). Then the sections were incubated simultaneously with an alkaline
phosphatase-labeled sheep anti-FITC antibody and an horseradish peroxid-
ase-conjugated avidin–biotin complex (both diluted in PBS/0.05% Tween
20) for 1 h. Antibody binding was visualized by incubating the skin sections
first in a Tris–HCl buffer (pH 5 8.5), containing 25 mg Fast Blue BB salt,
12.5 mg naphthol AS-MX phosphate, and 35 mg levamisol per 100 ml,
all purchased from Sigma. The slides were subsequently incubated with a
0.1 M acetate buffer (pH 5 5) containing 20 mg 3-amino-ethyl-carbazole
and 100 µl 30% H2O2 per 100 ml. Negative staining controls were used
in single- and double-staining experiments in which the first antibody was
omitted or was replaced by an irrelevant antibody of the same isotype. All
antibody incubations were performed in a humidified chamber at room
temperature. After each antibody incubation the slides were rinsed three
times in PBS containing 0.05% Tween 20.
The skin sections were evaluated using a light microscope at 250 times
magnification with a standard eyepiece. The number of positive cells in
the skin sections was assessed independently by two investigators. The
prevalence of cells was graded as: no or hardly any positive cells present
(–), presence of scattered positive cells (6), clear abundant presence of
positive cells (1), closed maze of positive cells (11).
The staining for epidermal CD1a1 cells and epidermal CD11b1 cells
was also determined quantitatively by image processing: The percentage
of epidermal cross-sectional area that was stained CD1a1 or CD11b1 was
measured, using a camera mounted on a light microscope together with
the Optimas 6.1 and Microsoft Excel software (the targeted interfollicular
epidermal area was demarcated manually).
Statistical analysis After logarithmic transformation (as the distribution
of the percentages of stained cross-sectional areas is skewed to the right),
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Table I. Semi-quantitative analysis of CD1aF cells (median) in the unexposed and UVB irradiated buttock skin of healthy
volunteers and PLE patientsa
Healthy volunteers (n 5 8)
epidermis dermis
PLE
normal MED (n 5 5) low MED (n 5 5)
epidermis dermis epidermis dermis
–UVB 1/11b –/6 11 – 11 6
(p , 0.05)
1UVB (48 h) – – 1 6 11 1
(p , 0.01) (p , 0.05) (p , 0.01) (p , 0.05)
aStatistical significance (p value) is given for PLE patients compared with healthy individuals. Where no p value is given, no significant difference was observed.
b 11, closed maze of positive cells; 1, clear abundant presence of positive cells; 6, presence of scattered positive cells; –, no or hardly any positive cells present.
Table II. Semi-quantitative analysis of CD11bF macrophage-like cells (median) in the unexposed and UVB irradiated
buttock skin of healthy volunteers and PLE patientsa
Healthy volunteers (n 5 8)
epidermis dermis
PLE
normal MED (n 5 5) low MED (n 5 5)
epidermis dermis epidermis dermis
–UVB –b 1 – 6 – 1
1UVB (48 h) 1 11 6 1 6 11
(p , 0.05) (p , 0.05)
aStatistical significance (p value) is given for PLE patients compared with healthy individuals. Where no p value is given, no significant difference was observed.
b 11, closed maze of positive cells; 1, clear abundant presence of positive cells; 6, presence of scattered positive cells; –, no or hardly any positive cells present.
a Student’s t test was performed on the CD1a1 log-% values to compare
PLE outcomes with those of healthy volunteers. Median values were
estimated as means of log-% values. A Wilcoxon rank sum test was
performed on the quantitative data of the epidermal CD11b1 area. The
same test was also used on the semiquantitative data (scored –, 6, 1, 11)
to compare the number of CD1a and CD11b positive cells either in the
epidermis or the dermis, e.g., comparing PLE patients with healthy
volunteers at 48 h after 6 MED (Figs 4, 5 and Tables I and II).
RESULTS
Phototesting assay In making a reproducible assay for analyzing
the reactions of CD1a1 Langerhans cells and CD11b1 macrophage-
like cells, we varied the UVB dose (3–6 MED) and location of
exposure in a group of healthy individuals. It appeared that buttock
skin, which had not been exposed to sunlight for at least 2 mo,
was the location that showed the most consistent effects of UVB
on the CD1a1 and CD11b1 cell populations. In our hands, a UVB
dose of 6 MED turned out to be adequate for the virtually complete
disappearance of CD1a1 Langerhans cells from the epidermis and
a clear influx of CD11b1 cells in all healthy volunteers tested.
These results are in accordance with earlier reports that Langerhans
cells disappeared and CD11b1 cells infiltrated the skin of healthy
individuals 48 h after UVB (Aberer et al, 1981; Cooper et al, 1986;
Meunier et al, 1995). After establishing this assay in healthy
volunteers, PLE patients and more healthy volunteers were included
in the study. PLE patients were divided into two subgroups: one
with normal MED and one with extremely low MED.
UV radiation induces disappearance of Langerhans cells in
healthy individuals but not in PLE patients The buttock skin
of PLE patients looked normal and unaffected before UVB expo-
sure. After 6 MED UVB exposure the skin was red and a little
swollen, but no pathology could be observed. In the unaffected
and unexposed skin of PLE patients CD1a1 cells were present in
vast amounts in the epidermis (Fig 1B), especially in the low MED
group (Fig 1C). All PLE patients demonstrated CD1a1 cells in the
upper dermis (Table I). The number of epidermal CD1a1 cells in
the unexposed skin of healthy volunteers (example in Fig 1A)
varied widely. Forty-eight hours after UVB irradiation CD1a1
Langerhans cells had disappeared from the epidermis of the healthy
volunteers (Fig 1D). In the dermis there were hardly any CD1a1
cells present. Several CD1a1 cells were still present in the epidermis
of PLE patients (Fig 1E) 48 h after the overexposure, especially in
the epidermis of PLE patients with a low MED (Fig 1F). Counting
of Langerhans cells in microscopic cross-sections is cumbersome
owing to the scattered presence of dendrites. To quantitate object-
ively whether the number of Langerhans cells in patients was
significantly different from the numbers seen in healthy volunteers,
we compared percentages of epidermal cross-sectional areas that
stained CD1a1. The cross-sectional area that stained CD1a1 in the
epidermis of PLE patients (median of 7% for PLE patients with a
normal MED and 13% for PLE patients with a low MED) was
significantly larger (p , 0.01) than in healthy individuals (median
of 0.55%) 48 h after 6 MED UVB exposure (Fig 2). No correlation
could be found between the absolute UV dose and the percentage
change in CD1a1 area after UV irradiation among healthy volun-
teers or among PLE patients with a normal MED or among healthy
individuals and PLE patients with a normal MED combined.
The semiquantitative scoring of the CD1a staining, analyzed by
the Wilcoxon rank sum test (Table I), also confirmed this significant
difference (p , 0.01) between the number of epidermal CD1a1
cells in healthy volunteers and PLE patients 48 h after UVB
radiation. The number of CD1a1 cells in the dermis of the UVB-
exposed skin of PLE patients was significantly larger compared
with healthy volunteers (p , 0.05). The number of epidermal and
dermal CD1a1 cells in the unexposed buttock skin did not differ
significantly (p . 0.05) between healthy volunteers and PLE
patients with a normal MED. In PLE patients with a low MED,
however, the number of dermal CD1a1 cells in the unexposed
skin was significantly larger than in healthy individuals (p , 0.05).
The number of epidermal CD1a1 cells did not differ significantly
between PLE patients with low MED and healthy volunteers
(p . 0.05). The changes in CD1a1 cells after UVB exposure are
only significant for epidermal CD1a1 cells in healthy individuals
(p , 0.01) and PLE patients with a normal MED (p , 0.05).
Characterization of the persistent CD1aF cells To character-
ize the persistent CD1a1 cells in the epidermis, the Birbeck
granules, characteristic of Langerhans cells, were visualized by
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Figure 1. CD1a staining of buttock
skin. (A–C) Unexposed (–UV) and
(D–F) 48 h after UVB exposure (1 UV
1 48 h). Scale bar : 50 µm.
Figure 2. Percentage epidermal CD1aF cross-sectional area of
buttock skin before (–UV) and 48 h after UVB irradiation (F UV
F 48 h). Comparisons of PLE patients with healthy volunteers are shown
(statistical significance: *p , 0.05; **p , 0.01). Medians are given together
with the standard errors.
immunohistochemical staining with the Lag antibody (Kashihara
et al, 1986). It appeared that all epidermal CD1a1 cells in healthy
volunteers as well as in PLE patients had Birbeck granules. The
CD1a1 cells that persisted in the epidermis of PLE patients after
6 MED UVB radiation also stained for the presence of Birbeck
granules. The dermal CD1a1 cells were always Lag negative (data
not shown).
UV radiation induces infiltration of CD11bF cells in the
epidermis, but to a lesser extent in PLE patients with normal
MED In the unexposed and unaffected buttock skin of healthy
volunteers and PLE patients, CD11b1 cells were already present
in the dermis, not in the epidermis (Fig 3A–C, Table II). The
number of these cells did not vary significantly (p . 0.05) between
the volunteers and the PLE patients, when the quantitative and
semiquantitative data were analyzed with the Wilcoxon rank sum
test (Table II). The number of CD11b1 macrophage-like cells in
the dermis increased 48 h after UVB exposure, but no significant
difference could be observed between the healthy volunteers and
the PLE patients (p . 0.05) (Fig 3D–F). An influx of CD11b1
cells in the epidermis of the volunteers (median of 3.3%) and the
PLE patients (median of 0.66% for PLE patients with a normal
MED and 3.36% for PLE patients with a low MED) (Fig 3E, F)
occurred 48 h after UVB irradiation. The influx of CD11b1 cells
in the epidermis was significantly smaller in PLE patients with a
normal MED than in healthy volunteers (p , 0.05; one-sided).
No significant difference could be observed when the CD11b1
log-% values of PLE patients with a low MED were compared
with healthy volunteers (Fig 4). All changes in CD11b after UVB
exposure were significant, except for those in epidermis and dermis
of PLE patients with a normal MED.
Differences in epidermal morphology When comparing the
epidermis of healthy volunteers and PLE patients 48 h after UVB
irradiation, a clear difference in the condition of the epidermis
was observed. In healthy volunteers thickening of the epidermis
occurred and the epidermis showed gross defects just below the
stratum corneum (Figs 1D and 3D). In PLE patients there was
also a thickening of the epidermis, but the epidermis appeared
completely intact (Figs 1E, F and 3E, F). Near and in the defects
that appear in the epidermis of the healthy volunteers great numbers
of CD11b1 cells could be observed (Fig 3). Hardly any CD31 cells
could be observed in the UV-exposed epidermis (data not shown).
Characterization of the CD11bF cells To test if the CD11b1
cell was indeed belonging to the macrophage cell lineage, an
immunohistochemical double staining was performed with the
macrophage marker CD68 (Azzawi et al, 1997; Davidson et al,
1997). In healthy volunteers and PLE patients CD11b single
positive, CD68 single positive, and CD11b/CD68 double positive
cells could be observed in the unexposed and UV-exposed buttock
skin (Fig 5).
In the unexposed buttock skin of healthy volunteers CD11b/
CD68 double positive cells were present in the upper dermis and
mid-dermis. CD68 single positive cells were mostly present in the
deeper part of the dermis. There were hardly any CD11b single
positive cells present in the dermis of healthy volunteers (Fig 5A).
No single-stained or double-stained cells could be observed in the
epidermis.
Forty-eight hours after UVB exposure the number of CD11b
single positive cells increased markedly in the upper dermis of
healthy volunteers, whereas the number of CD11b/CD68 double
positive cells and CD68 single positive cells did not change or only
increased modestly (Fig 5C). The CD11b1 cells that infiltrated
the epidermis of healthy volunteers after UVB overexposure were
nearly all CD11b single positive (Fig 5), some were CD68 single
positive or CD11b/CD68 double positive.
In contrast, nearly all CD11b1 cells in the unexposed skin of
PLE patients were also CD68 positive (Fig 5B). A small number
of CD68 single positive cells could be observed in the mid-dermis
and in the deeper parts of the dermis. After UVB exposure the
number of dermal CD11b/CD68 double positive cells increased
markedly (Fig 5D). In some PLE patients the number of CD68
single positive cells also increased. Hardly any CD11b single positive
cells could be observed. The few cells that infiltrate the epidermis
after UVB irradiation were also all CD11b/CD68 double positives,
very much in contrast with the influx of CD11b single positive
cells in the epidermis of healthy individuals.
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Figure 3. CD11b staining of buttock
skin. (A–C) Unexposed (–UV) and (D–
F) 48 h after UVB exposure (1 UV 1 48
h). Scale bar : 50 µm.
Figure 4. Percentage epidermal CD11bF cross-sectional area of
buttock skin before (–UV) and 48 h after UVB irradiation (F UV
F 48 h). Comparisons of PLE patients with healthy individuals are shown
(statistical significance: *p , 0.05; **p , 0.01). Medians are given together
with the standard errors.
Figure 5. Double staining of CD11b and CD68 of buttock skin.
Blue, CDIIb; red, CD68; (A,B) unexposed (–UV) and (C–D) 48 h after
UVB exposure (1 UV 1 48 h). The epidermis was demarcated manually.
Scale bar : 50 µm.
DISCUSSION
This study was based on the supposition that a pathologic skin
reaction may be evoked by UVB exposure if a defect occurs
in the normally induced suppression of cellular immunity. We
hypothesized that the influx of immunosuppressive, interleukin-10
producing CD11b1 cells (Kang et al, 1994, 1998) could be absent
or dysfunctional in some way in PLE patients, in whom pathologic
reactions could be provoked by UVB radiation. CD11b1 cells
were present in the dermis of the unexposed and UV-exposed
buttock skin of PLE patients. The number of dermal CD11b1 cells
did, however, increase in the uninvolved buttock skin of these
patients after UVB irradiation, and was not significantly different
from that in healthy individuals. No CD11b1 cells could be
observed in the epidermis of the unexposed buttock skin of healthy
volunteers and PLE patients. Remarkably, after UV exposure the
influx of CD11b1 cells in the epidermis of PLE patients with
normal MED was indeed significantly less than in healthy volunteers,
but in PLE patients with low MED the influx of CD11b1 cells
was comparable with that in healthy volunteers.
A far more striking difference between healthy volunteers and
PLE patients occurred, however, in the response of CD1a1
Langerhans cells to UVB overexposure. Persistent CD1a1 cells
could be observed in the epidermis of PLE patients 48 h after 6
MED UVB exposure, whereas in healthy individuals the Langerhans
cells completely disappeared from the epidermis. Because the UV
dose varied between healthy volunteers and PLE patients, the
question arose whether the disappearance of CD1a1 cells was
correlated to the absolute UV dose. There was, however, no
correlation between UV dose and percentage change in CD1a1
area: not among healthy individuals nor among PLE patients with
normal MED, and not even among these two groups combined.
The image processing which was used to quantitate CD1a1 cells
did not distinguish between lesser number of cells and a loss of
dendrites by rounding up of the cells. In healthy individuals it is
obvious that the effect of UV on Langerhans cells is a near complete
depletion (well over 80% decrease in stained area in seven of eight,
one with 64% reduction). In PLE patients the effect of UV on
Langerhans cells is due to decreases in cell number and partially
due to changes in cell morphology (all, n 5 10, decreases in stained
area well below 70%). This means that the differences between
CD1a1 cells of healthy volunteers and PLE patients after UV
irradiation are even underestimated. Immunohistochemical double
staining of the CD1a1 cells with the Lag antibody, directed against
Birbeck granules, confirmed that the persistent epidermal CD1a1
cells were indeed Langerhans cells. CD1a1 cells in the dermis were
mostly Lag negative.
The CD11b1 cells were further characterized by double staining
with the pan-macrophage marker CD68 (Azzawi et al, 1997;
Davidson et al, 1997). The CD11b1 cells that infiltrate the UV-
irradiated epidermis in healthy volunteers are mostly CD68 negative,
whereas the few CD11b1 cells that infiltrate the UV-exposed
epidermis of PLE patients are all CD68 positive. The dermal
CD11b1 cells in the unexposed and UV-exposed buttock skin of
PLE patients and healthy volunteers were mostly CD68 positive.
The CD11b1 cell population of PLE patients is therefore at least
partially different from the CD11b1 cell population of healthy
volunteers: different cells or cells in a different state of activation.
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Another interesting difference between PLE patients and healthy
individuals was observed: PLE patients appeared to have no
epidermal defects after UVB exposure, whereas all healthy indi-
viduals clearly did. In a study of Hammerberg et al (1996) anti-
CD11b treatment, of mice, partially protected against epidermal
UV injury: the epidermal structure was better preserved and
keratinocytes appeared less damaged. Knowing that the UV-
irradiated epidermis of the PLE patients showed a low influx of
CD11b1 cells and that the CD11b1 cells are lodged into the
defects in healthy volunteers, it is tempting to speculate that these
CD11b1 cells are, at least partially, responsible for the development
of the epidermal defects. In this regard, it is also noteworthy that
the epidermal CD11b1 cells of PLE patients are of a different
phenotype than those in healthy volunteers: namely CD681 versus
CD68–, respectively. Our hypothesis is that the CD11b1 CD68–
cell population in skin of the healthy volunteers consists to a large
extent of granulocytes, which by their release of tissue destructing
enzymes, can be responsible for the epidermal defects.
In mice UV-exposed Langerhans cells migrate from the epidermis
to present antigen to the T cells in the paracortex of the lymph
nodes (Halliday and Norval, 1997). The cytokine tumor necrosis
factor-α which is released in the skin after UV exposure, is involved
in this migration of Langerhans cells (Cumberbatch and Kimber,
1992; Moodycliffe et al, 1994; Boonstra and Savelkoul, 1997).
Persistence of UV-irradiated Langerhans cells in the epidermis of
PLE patients might thus be the result of a lack of tumor necrosis
factor-α secretion. Another potential effect of tumor necrosis
factor-α is the induction of apoptosis (Norris et al, 1997; Romano
et al, 1998). Apoptosis could also contribute to the depletion of
Langerhans cells in the skin of healthy individuals after UV
irradiation (Mommaas et al, 1993). Furthermore, a massive apoptosis
induced by high levels of tumor necrosis factor-α might be
responsible for the epidermal defects observed in healthy volunteers,
and a lack of tumor necrosis factor-α in PLE would then explain
the absence of epidermal defects.
One patient, who was initially included in the PLE group with
a normal MED, was later diagnosed with subacute cutaneous lupus
erythematosus (Nyberg et al, 1997) and excluded from the study.
The Langerhans cells in the epidermis of this person did also not
disappear 48 h after 6 MED UVB (data not shown). Thus, UV
resistance of Langerhans cells might be a prerequisite for UVB-
induced photodermatoses in general, and not specific for PLE.
The differences in UVB-triggered photodermatoses may then lie
in the differences in the antigenic stimuli that evoke the pathologic
reaction, e.g., UV-damaged DNA in the case of lupus
erythematosus.
In an initially extremely sun-sensitive PLE patient who received
a successful UV hardening therapy, we found that the Langerhans
cells disappeared from the epidermis 48 h after 6 MED over-
exposure. This preliminary first observation on re-adaptation would
appear to confirm and emphasize the importance of persisting
Langerhans cell in a photoreactive disease like PLE. These first
results need to be confirmed in our follow-up studies. The
importance of UV adaptation is also indicated by the observation
that PLE increases in prevalence and severity towards higher
northern latitudes, where the relative differences in UVB between
summer and winter are bigger. Loss of adaptation of the skin to
UV radiation (UVB) in winter would therefore appear to be of
paramount importance to the disease (van der Leun et al, 1993).
UV-resistant Langerhans cells were also observed by Torres-
Alavarez et al (1998) in actinic prurigo patients, but the difference
with healthy controls after 20 MED (!) UV irradiation were
considerably smaller than in our study. These researchers used an
unfiltered high-pressure quartz mercury lamp, a UVC/UVB source,
for skin irradiation, whereas we used TL-12 lamps which have
their main output in UVB. Overexposure to UVC is better
tolerated than overexposure to UVB (UVB erythema shows a
steeper dose-gradient), which could explain the marginal differences
that were observed by Torres-Alavarez et al (1998).
PLE is often provoked with UVA sources (Holze, 1995), e.g.,
with fluorescent lamps like the Philips TL09. But these broad-
band sources often do contain significant traces of UVB. The
UVA-1 region (340–400 nm) is more distinct from UVB (280–
315 nm) than the UVA-2 (315–340 nm) region in the type of
biologic response it evokes. Most PLE patients react pathologically
to UVA-1 as well as to UVB.1 Some patients also react to visible
light. In our study only PLE patients who reacted pathologically
to UVB irradiation alone, or to UVB and UVA, were included.
The patients who were included reacted stronger to UVB than to
UVA. As UV immunosuppression by UVA-1 or visible light is not
commonly observed in healthy individuals, it is more likely
that PLE reactions evoked by pure UVA-1 or visible light are
predominantly due to the generation of a neo-antigen to which
these individuals are sensitized. UVA-1 in absence of UVB will
not induce the appropriate immunosuppressive response. UVA-1
may actually enhance cellular responses by inducing interferon-γ.2
The observed deviations in the epidermal infiltration of CD11b1
cells after UVB exposure may well play a part in the initial immune
reactivity leading to PLE skin lesions, because the CD11b1 cells
appear to mediate immunosuppression in healthy individuals (Kang
et al, 1994, 1998; Hammerberg et al, 1996). UV-exposed Langerhans
cells can also contribute to immunosuppression, as demonstrated
in mice (Simon et al, 1991). A consequence of the abnormal
persistence of Langerhans cells in the overexposed epidermis of
PLE patients could well be the presentation of UV-induced neo-
antigens at the wrong location, namely in the skin instead of in
the draining lymph nodes, thus resulting in an illicit immune
reaction in the skin instead of an immunosuppressive response in
the lymph nodes. This persistence of CD1a1 cells after UVB
overexposure may serve as an important diagnostic criterion for
UVB-related photodermatoses.
Clearly, the precise mechanisms for photodermatoses and PLE
in particular need further elucidation, but the aberrant reaction of
Langerhans cells to UV irradiation appears to be a prerequisite.
We would like to thank Jan van der Linden from the Department of Pulmonary
Diseases, University Hospital Utrecht for his support in image processing of the
CD1a1 and CD11b1 cells.
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